29 related articles for article (PubMed ID: 16231322)
1. Potentiation of paclitaxel cytotoxicity by inostamycin in human small cell lung carcinoma, Ms-1 cells.
Simizu S; Tanabe K; Tashiro E; Takada M; Umezawa K; Imoto M
Jpn J Cancer Res; 1998 Sep; 89(9):970-6. PubMed ID: 9818034
[TBL] [Abstract][Full Text] [Related]
2. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.
Trapasso F; Krakowiak A; Cesari R; Arkles J; Yendamuri S; Ishii H; Vecchione A; Kuroki T; Bieganowski P; Pace HC; Huebner K; Croce CM; Brenner C
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1592-7. PubMed ID: 12574506
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells.
Pearce MC; Gamble JT; Kopparapu PR; O'Donnell EF; Mueller MJ; Jang HS; Greenwood JA; Satterthwait AC; Tanguay RL; Zhang XK; Kolluri SK
Oncotarget; 2018 May; 9(40):26072-26085. PubMed ID: 29899843
[TBL] [Abstract][Full Text] [Related]
4. Retraction: Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non-small cell lung cancer cells via Nrf2 inhibition.
Br J Pharmacol; 2024 Apr; 181(8):1342. PubMed ID: 38439643
[No Abstract] [Full Text] [Related]
5. N-Terminal Domain of Fragile Histidine Triad Exerts Potent Cytotoxic Effect in HT1080 Cells and Increases Doxorubicin Cytotoxicity.
Eslamparast A; Abbasgholizadeh R; Ostad SN; Gharghabi M; Ghahremani MH
Iran J Pharm Res; 2019; 18(1):254-262. PubMed ID: 31089360
[TBL] [Abstract][Full Text] [Related]
6. F10, a novel hydatidiform mole-associated gene, inhibits the paclitaxel sensitivity of A549 lung cancer cells by downregulating BAX and caspase-3.
Song Y; Cao W; Zhu X; Qiu Z; Yang X; Liu J; Xu R; Yuan W; Quan S
Oncol Lett; 2017 Apr; 13(4):2563-2568. PubMed ID: 28454434
[TBL] [Abstract][Full Text] [Related]
7. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.
Gaudio E; Paduano F; Ngankeu A; Ortuso F; Lovat F; Pinton S; D'Agostino S; Zanesi N; Aqeilan RI; Campiglia P; Novellino E; Alcaro S; Croce CM; Trapasso F
Oncotarget; 2016 May; 7(21):29927-36. PubMed ID: 27166255
[TBL] [Abstract][Full Text] [Related]
8. Anti-carcinogenic effects of the phenolic-rich extract from abnormal Savda Munziq in association with its cytotoxicity, apoptosis-inducing properties and telomerase activity in human cervical cancer cells (SiHa).
Abliz G; Mijit F; Hua L; Abdixkur G; Ablimit T; Amat N; Upur H
BMC Complement Altern Med; 2015 Feb; 15():23. PubMed ID: 25880193
[TBL] [Abstract][Full Text] [Related]
9. FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.
Wu DW; Lee MC; Hsu NY; Wu TC; Wu JY; Wang YC; Cheng YW; Chen CY; Lee H
Oncogene; 2015 May; 34(19):2505-15. PubMed ID: 24998847
[TBL] [Abstract][Full Text] [Related]
10. Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.
Gaudio E; Paduano F; Spizzo R; Ngankeu A; Zanesi N; Gaspari M; Ortuso F; Lovat F; Rock J; Hill GA; Kaou M; Cuda G; Aqeilan RI; Alcaro S; Croce CM; Trapasso F
PLoS One; 2013; 8(11):e78610. PubMed ID: 24223161
[TBL] [Abstract][Full Text] [Related]
11. Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines.
Pasini A; Paganelli G; Tesei A; Zoli W; Giordano E; Calistri D
Transl Oncol; 2012 Dec; 5(6):461-8. PubMed ID: 23397475
[TBL] [Abstract][Full Text] [Related]
12. Src family kinases and paclitaxel sensitivity.
Le XF; Bast RC
Cancer Biol Ther; 2011 Aug; 12(4):260-9. PubMed ID: 21646863
[TBL] [Abstract][Full Text] [Related]
13. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.
Stewart DJ
Crit Rev Oncol Hematol; 2010 Sep; 75(3):173-234. PubMed ID: 20047843
[TBL] [Abstract][Full Text] [Related]
14. FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.
Kim CH; Yoo JS; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
Int J Cancer; 2006 Apr; 118(7):1692-8. PubMed ID: 16231322
[TBL] [Abstract][Full Text] [Related]
15. The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.
Roz L; Andriani F; Ferreira CG; Giaccone G; Sozzi G
Oncogene; 2004 Dec; 23(56):9102-10. PubMed ID: 15489891
[TBL] [Abstract][Full Text] [Related]
16. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
Jayachandran G; Sazaki J; Nishizaki M; Xu K; Girard L; Minna JD; Roth JA; Ji L
Cancer Res; 2007 Nov; 67(21):10379-88. PubMed ID: 17974981
[TBL] [Abstract][Full Text] [Related]
17. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.
Roz L; Gramegna M; Ishii H; Croce CM; Sozzi G
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3615-20. PubMed ID: 11891319
[TBL] [Abstract][Full Text] [Related]
18. Fragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway.
Huang Q; Liu Z; Xie F; Liu C; Shao F; Zhu CL; Hu S
ScientificWorldJournal; 2014; 2014():179698. PubMed ID: 24757411
[TBL] [Abstract][Full Text] [Related]
19. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
